Theranostic Nanomedicine for Malignant Gliomas
نویسندگان
چکیده
منابع مشابه
Theranostic nanomedicine for cancer.
Baran Sumer1, Jinming Gao2† †Author for correspondence 1Department of Otolaryngology, Head and Neck Surgery, UT Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390, USA Tel.: +1 214 648 3102; Fax: +1 214 648 2246; E-mail: baran.sumer@ utsouthwestern.edu 2Department of Pharmacology, Harold C Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, 5...
متن کاملPersonalized NanoMedicine: Towards new Theranostic Approach
Since decades, researchers are seeking novel therapeutic strategies to cure and monitor diseases for personalized health care needs. Numerous successful efforts are being made to design and develop personalized NanoMedicine approach to cure diseases at target site with minimum or no adverse effects. The designing of novel nanomaterials, maximum binding with therapeutic agent, controlled navigat...
متن کاملA Smart and Versatile Theranostic Nanomedicine Platform based on Nanoporphyrin
Multifunctional nanoparticles with combined diagnostic and therapeutic functions show great promise towards personalized nanomedicine. However, attaining consistently high performance of these functions in vivo in one single nanoconstruct remains extremely challenging. Here we demonstrate the use of one single polymer to develop a smart 'all-in-one' nanoporphyrin platform that conveniently inte...
متن کاملCellular immunotherapy for malignant gliomas.
INTRODUCTION Cancer immunotherapy has made much progress in recent years. Clinical trials evaluating a variety of immunotherapeutic approaches are underway in patients with malignant gliomas. Thanks to recent advancements in cell engineering technologies, infusion of ex vivo prepared immune cells have emerged as promising strategies of cancer immunotherapy. AREAS COVERED Herein, the authors r...
متن کاملGene Therapy for Malignant Gliomas
Retroviruses are enveloped RNA viruses that possess the ability to integrate into the host cell genome by transcribing DNA from their RNA template via viral reverse transcriptase. The transcribed viral DNA is then integrated into the host cell genome nonspecifically. There is relative specificity for tumors because, except for lentiviruses, retroviral DNA preferentially integrates into the geno...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Frontiers in Bioengineering and Biotechnology
سال: 2019
ISSN: 2296-4185
DOI: 10.3389/fbioe.2019.00325